Plasmalogen is a subclass of phospholipids that is widely distributed in man and animals. Many physiological roles have been proposed for this lipid; however, there have been no reports on the intestinal absorption of plasmalogen. In the present study, we examined lymphatic absorption of plasmalogen after the duodenal infusion of emulsified brain phospholipids (BPL) containing plasmalogen (22 mol % of total phospholipids) and soyabean lecithin (SPL) (100 g emulsified phospholipid/l). Male Wistar rats with implanted cannulas in the mesenteric lymph duct and the duodenum were kept in a Bollman-type restraining cage, and were infused the emulsion after 1 d recovery with duodenal infusion of a glucose-NaCl solution. Lymphatic plasmalogen output was increased at 2-4 h after the switch to BPL emulsion, and peaked at 4-6 h. However, no increases were observed after SPL infusion. Lymphatic recovery of plasmalogen for 8 h was 198 nmol, which was 0.22 mol % of the total plasmalogen disappeared from the intestine. We did not detect any increases in long-chain fatty aldehydes, which are the degradation product of plasmalogen, either in the blood or the small intestine. We conclude that a small percentage but a significant amount of the plasmalogen was absorbed into the lymph.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1079/bjn2003879 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lymphatic absorption characteristics of eicosapentaenoic acid -enriched phosphoethanolamine plasmalogen and its gastric and intestinal hydrolysates.
Food Chem
January 2025
SKL of Marine Food Processing & Safety Control, College of Food Science and Engineering, Ocean University of China, No.1299 Sansha Road, Qingdao 266404, PR China; Sanya Institute of Oceanography, Ocean University of China, Sanya 572000, PR China. Electronic address:
Article Synopsis
- The study investigated how well the body absorbs different forms of eicosapentaenoic acid (EPA) through lymphatic pathways, comparing gastric and intestinal hydrolysates of EPA-enriched phosphoethanolamine plasmalogen (EPA-pPE).
- Findings showed that EPA peaks in gastric and intestinal hydrolysates occurred earlier and at higher concentrations compared to EPA-pPE, indicating that pre-hydrolysis enhances lymphatic absorption.
- Additionally, different forms of EPA from hydrolysates influenced the production of various lipid compounds in the lymph fluid, providing valuable insights into how dietary structures affect EPA metabolism.
Lipidomics and metabolomics investigation into the effect of DAG dietary intervention on hyperuricemia in athletes.
J Lipid Res
September 2024
School of Food Science and Engineering, South China University of Technology, Guangzhou, Guangdong, China. Electronic address:
The occurrence of hyperuricemia (HUA; elevated serum uric acid) in athletes is relatively high despite that exercise can potentially reduce the risk of developing this condition. Although recent studies have shown the beneficial properties of DAG in improving overall metabolic profiles, a comprehensive understanding of the effect of DAG in modulating HUA in athletes is still lacking. In this study, we leveraged combinatorial lipidomics and metabolomics to investigate the effect of replacing TAG with DAG in the diet of athletes with HUA.
View Article and Find Full Text PDFParallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition.
ACS Chem Neurosci
April 2024
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague 6 166 10, Czechia.
Glutamate carboxypeptidase II (GCPII, also known as PSMA or FOLH1) is responsible for the cleavage of -acetyl-aspartyl-glutamate (NAAG) to -acetyl-aspartate and glutamate in the central nervous system and facilitates the intestinal absorption of folate by processing dietary folyl-poly-γ-glutamate in the small intestine. The physiological function of GCPII in other organs like kidneys is still not known. GCPII inhibitors are neuroprotective in various conditions (e.
View Article and Find Full Text PDFLipidomics reveal the cognitive improvement effects of seed oil on hypoxic-ischemic encephalopathy rats.
Food Funct
July 2023
Department of Pediatrics, Shengjing Hospital of China Medical University, Plateau Medical Research Center of China Medical University, Shenyang, China.
Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of acute neonatal death and chronic neurological damage, and severe HIE can have secondary sequelae such as cognitive impairment and cerebral palsy, for which effective interventions are lacking. In this study, we found that continuous 30-day intake of seed oil (ASO) reduced brain damage and improved cognitive ability in HIE rats. Using lipidomic strategies, we observed that HIE rats had decreased unsaturated fatty acids and increased lysophospholipids in the brain.
View Article and Find Full Text PDFPharmacokinetics, Mass Balance, Excretion, and Tissue Distribution of Plasmalogen Precursor PPI-1011.
Front Cell Dev Biol
April 2022
Med-Life Discoveries LP, Saskatoon, SK, Canada.
PPI-1011 is a synthetic plasmalogen precursor in development as a treatment for multiple plasmalogen-deficiency disorders. Previous work has demonstrated the ability of PPI-1011 to augment plasmalogens and its effects and , however, the precise uptake and distribution across tissues has not been investigated. The purpose of this study was to evaluate the pharmacokinetics, mass balance, and excretion of [C]PPI-1011 following a single oral administration at 100 mg/kg in Sprague-Dawley rats.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!